查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032778

全球臨床前影像市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Preclinical Imaging Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 159 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球臨床前影像市場預計將從2025年的49億美元成長至2034年的75.4億美元，2026年至2034年的複合年成長率（CAGR）為4.91%。隨著製藥和生物技術公司越來越依賴先進的成像技術來加速藥物發現和開發，該市場正在快速擴張。磁振造影（MRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）和光學成像等臨床前影像系統被用於研究動物模型中的疾病進展並評估治療反應。對精準醫療的日益重視以及對早期檢驗藥物療效的需求不斷成長是推動市場成長的主要因素。此外，生命科學領域研發投入的增加也進一步促進了市場的擴張。

關鍵成長要素包括技術進步和對非侵入性成像技術日益成長的需求。現代臨床前成像系統提供高解析度的即時資訊，使研究人員能夠更有效地監測生物過程。學術研究機構和受託研究機構(CRO) 的擴張也推動了市場成長。此外，慢性病盛行率的上升加速了新治療方法的研發，進而推動了對先進影像解決方案的需求。

該市場的未來前景仍然十分光明，持續的創新可望提升成像能力和效率。人工智慧 (AI) 和數據分析的融合將改善影像解讀並圖研究成果的轉化。隨著新興市場研究基礎設施的不斷完善，預計將迎來顯著成長。隨著對先進藥物研發工具的需求持續攀升，臨床前影像市場可望持續擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球臨床前影像市場：依產品分類

  • 市場分析、洞察與預測
  • CT影像
  • 磁振造影
  • PET/SPECT影像
  • 多模態成像
  • 光學成像
  • 超音波成像
  • 光聲成像
  • 試劑
  • 服務

第5章 全球臨床前影像市場：依應用領域分類

  • 市場分析、洞察與預測
  • 研究與開發
  • 藥物發現

第6章 全球臨床前影像市場：依最終用途分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 研究機構
  • 其他

第7章 全球臨床前影像市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 對中東和非洲市場的分析、洞察和預測。
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Bruker Corporation
    • Siemens AG
    • General Electric（GE）
    • TriFoil Imaging
    • PerkinElmer Inc
    • Fujifilm SonoSite
    • Mediso Ltd
    • Agilent Technologies
    • MILabs BV
    • MR Solutions
    • Molecubes
簡介目錄
Product Code: VMR11219515

The global preclinical imaging market size is expected to reach USD 7.54 Billion in 2034 from USD 4.90 Billion in 2025, growing at a CAGR of 4.91 during 2026-2034.This market is expanding rapidly as pharmaceutical and biotechnology companies increasingly rely on advanced imaging technologies to accelerate drug discovery and development. Preclinical imaging systems, including MRI, CT, PET, and optical imaging, are used to study disease progression and evaluate therapeutic responses in animal models. The growing emphasis on precision medicine and the need for early-stage validation of drug efficacy are significantly driving market growth. Additionally, rising investments in research and development activities across the life sciences sector are further contributing to the expansion of this market.

Key growth drivers include technological advancements and the increasing demand for non-invasive imaging techniques. Modern preclinical imaging systems offer high-resolution and real-time insights, enabling researchers to monitor biological processes more effectively. The expansion of academic research institutions and contract research organizations is also supporting market growth. Furthermore, the increasing prevalence of chronic diseases is encouraging the development of new therapies, which in turn drives demand for advanced imaging solutions.

Future prospects for this market remain highly promising, with continued innovation expected to enhance imaging capabilities and efficiency. The integration of artificial intelligence and data analytics will improve image interpretation and accelerate research outcomes. Emerging markets are likely to witness significant growth due to expanding research infrastructure. As the demand for advanced drug development tools continues to rise, the preclinical imaging market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multi-modal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic Imaging
  • Reagents
  • Services

By Application

  • Research and Development
  • Drug Discovery

By End-use

  • Pharma and Biotech Companies
  • Research Institutes
  • Others

COMPANIES PROFILED

  • Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer Inc., Fujifilm SonoSite, Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, Molecubes.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECLINICAL IMAGING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. CT Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. MRI Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. PET/SPECT Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Multi-modal Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Optical Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Ultrasound Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Photoacoustic Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECLINICAL IMAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECLINICAL IMAGING MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Pharma and Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECLINICAL IMAGING MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRECLINICAL IMAGING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Bruker Corporation
    • 9.2.2 Siemens A.G
    • 9.2.3 General Electric (GE)
    • 9.2.4 TriFoil Imaging
    • 9.2.5 PerkinElmer Inc
    • 9.2.6 Fujifilm SonoSite
    • 9.2.7 Mediso Ltd
    • 9.2.8 Agilent Technologies
    • 9.2.9 MILabs B.V
    • 9.2.10 MR Solutions
    • 9.2.11 Molecubes